[Bravo, A. A., Sheth, S. G., Chopra, S. (2001). Liver biopsy. New Engl. J. Med., 344, 495–500.10.1056/NEJM200102153440706]Search in Google Scholar
[Hettmansperger, T. P., McKean, J. W. (2011). Robust Nonparametric Statistical Methods. 2nd ed., New York, Chapman-Hall. 554 pp.10.1201/b10451]Search in Google Scholar
[Kaspar, M. B., Sterling, R. K. (2017). Mechanisms of liver disease in patients infected with HIV. BMJ Open Gastro, 4, e000166.10.1136/bmjgast-2017-000166]Search in Google Scholar
[Kim H. N., Nance, R., Rompaey, S. V., Delaney, J. C., Crane, H. M., Cachay, E. R., Geng, E., Boswell, S. L., Rodriguez, B., Eron, J., Saag, M., Moore, R. D., Kitahata, M. M. (2016). Poorly controlled HIV infection: An independent risk factor for liver fibrosis. J. Acquir. Immune Defic. Syndr., 72 (4), 437–443.10.1097/QAI.0000000000000992]Search in Google Scholar
[Kloke, J. D., McKean, J. W. (2012). Rfit: Rank-based estimation for linear models rank-regression. The R. Journal, 4 (2), 57–64.10.32614/RJ-2012-014]Search in Google Scholar
[Konerman, M. A., Mehta, S. H., Sutcliffe, C. G., Vu, T., Higgins, Y., Torbenson, M. S., Moore, R. D., Thomas, D. L., Sulkowski, M. S. (2014). Fibrosis progression in human immunodeficiency virus/hepatitis C virus coinfected adults: Prospective analysis of 435 liver biopsy pairs. Hepatol. Baltim. Md., 59, 767–775.10.1002/hep.26741]Search in Google Scholar
[Larrousse, M., Laguno, M., Segarra, M., De Lazzari, E., Martinez, E., Luis Blanco, J. L., León, A., Deulofeu, R., Miquel, R., Milinkovic, A., Lonca, M., Miró, J. M., Biglia, A., Murillas, J., Gatell, J. M., Mallolas, J. (2007). Noninvasive diagnosis of hepatic fibrosis in HIV/HCV-coinfected patients. J. Acquir. Immune Defic. Syndr., 46, 304–311.10.1097/QAI.0b013e3181520502]Search in Google Scholar
[Neuman, M. G., Cohen, L. B., Nanaua R. M. (2016). Hyaluronic acid as a non-invasive biomarker of liver fibrosis. Clin. Biochem., 49, 302–315.10.1016/j.clinbiochem.2015.07.019]Search in Google Scholar
[Peters, L., Neuhaus, J., Mocroft, A., Soriano, V., Rockstroh, J., Dore, G., Puoti, M., Tedaldi, E., Clotet, B., Kupfer, B., Lundgren, J. D., Klein, M. B., for the INSIGHT SMART Study Group. (2011). Hyaluronic acid levels predict increased risk of non-AIDS death in hepatitis-coinfected persons interrupting antiretroviral therapy in the SMART Study. Antivir. Ther.16 (5), 667–675.10.3851/IMP1815]Search in Google Scholar
[Qurishi, N., Kreuzberg, C., Lüchters, G., Effenberger, W., Kupfer, B., Sauerbruch, T., Rockstroh, J. K., Spengler, U. (2003). Effect of anti-retroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection. Lancet, 362, 1708–1713.10.1016/S0140-6736(03)14844-1]Search in Google Scholar
[Schmid, P., Bregenzer, A., Huber, M., Rauch, A., Jochum, W., Müllhaupt, B., Vernazza, P., Opravil, M., Weber, R., Swiss HIV Cohort Study. (2015). Progression of liver fibrosis in HIV/HCV co-infection: A comparison between non-invasive assessment methods and liver biopsy. PLoS ONE, 10 (9), e0138838.10.1371/journal.pone.0138838458785926418061]Search in Google Scholar
[Sterling, R. K., Lissen, E., Clumeck, N., Sola, R., Cassia, M., Correa, M.C., Montaner, J., Sulkowski, M. S., Torriani, F. J., Dieterich, D. T., Thomas, D. L., Messinger, D., Nelson, M. for the APRICOT Clinical Investigators. (2006). Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatol. Baltim. Md, 43, 1317–1325.10.1002/hep.2117816729309]Search in Google Scholar